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Thank you for the submission of your manuscript to EMBO reports. We have now received the full set of referee reports that is copied below.
As you will see, the referees agree that the findings are interesting and that the data are convincing. However, they also make suggestions for how the study could be further improved. Both referees 1 and 2 point out that it should be investigated whether ATR phosphorylates SOG1 in response to replication stress. Referee 1 further indicates that the functional relationship between SOG1, p53 and p63 should be discussed in a little more detail. Referee 3 also feels that the ATM phosphorylation sites on SOG1 should be identified. If this experiment can be performed within 3 months, then I agree that it would be a useful addition to the manuscript. However, if you think differently, please let me know, and we can discuss this issue further.
Given these positive and constructive comments, we would like to invite you to revise your manuscript with the understanding that the referee concerns must be fully addressed and their suggestions taken on board. Acceptance of the manuscript will depend on a positive outcome of a second round of review. It is EMBO reports policy to allow a single round of revision only and acceptance or rejection of the manuscript will therefore depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. Also, the revised manuscript may not exceed 30,000 characters (including spaces and references) and 5 figures plus 5 supplementary figures, which should directly relate to their corresponding main figure.
We also recently decided to offer the authors the possibility to submit "source data" with their revised manuscript that will be published in a separate supplemental file online along with the accepted manuscript. If you would like to use this opportunity, please submit the source data (for example entire gels or blots, data points of graphs, additional images, etc.) of your key experiments together with the revised manuscript.
We would also welcome the submission of cover suggestions, or motifs to be used by our Graphics Illustrator in designing a cover.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. This File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
You are able to opt out of this by letting the editorial office know (emboreports@embo.org). If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case." I look forward to seeing a revised version of your manuscript when it is ready.
REFEREE REPORTS:
Referee #1: This is an interesting manuscript describing mechanisms of DNA damage signaling in Arabidopsis. Arabidopsis possesses ATM and ATR homologs, but not Chk1, Chk2 or p53 homologs. Instead, the transcription factor SOG1 has been shown to function downstream of ATM and ATR in a manner analogous to that of p53. In this manuscript, the authors show that serine-glutamine (SQ) motifs of SOG1 are phosphorylated by ATM in response to DNA damage, providing a mechanism by which ATM activates SOG1. Further, they show that a SOG1 AQ mutant (that cannot be phosphorylated by ATM) is functionally inactive.
The experiments are well-performed. The authors demonstrate phosphorylation of SOG1 in vivo in an ATM-and DNA damage-dependent manner. Further, they have identified 5 SQ motifs that are the targets of ATM-dependent phosphorylation and they show that human ATM phosphorylates these motifs in vitro. As mentioned above, a SOG1 mutant that cannot be phosphorylated by ATM is functionally inactive.
My only question is why the authors did not examine whether ATR phosphorylates SOG1 in response to agents that induce DNA replication stress. It seems that it would be very easy for them to examine this (similar to Fig. 2E , except using an agent that induces DNA replication stress, instead of zeocin).
In conclusion, SOG1 is a very interesting protein. Functionally it behaves like p53. The only difference is that p53 protein levels are induced by DNA damage, whereas SOG1 protein levels are not affected by DNA damage. in this regard, SOG1 is closer to p63, whose activity, but not protein levels, is induced by DNA damage.
Referee #2:
This is a very elegant and concise work describing the activity of phosphorylated SOG1 in mediating ATM-dependent response to DNA damage. This is interesting in itself but is exciting as the results allow comparison of the activities of the plant derived SOG1 and mammalian p53 in mediateing damage response: although these proteins are unrelated in sequence they both depend on their own ATMs for becoming phosphorylated to be able to act as transcription factors regulating downstream activities.
I only have one critical comment: the experiment described in Fig S4 uses plants carrying the endogenous SOG gene as well as a transgenic one fused to myc. This results in unexpected levels of the two proteins which the authors suggest are due to gene silencing. It is not clear that this is the correct explanation, as in this case both proteins would be present at lower than expected levels. In order to present a clear picture the authors are asked to perform this experiment using sog-defective plants carrying the myc-labelled version. In the next paragraph on page 7 such plants are mentioned.
A small, only "political" comment concerns the mentioning of papers referenced as #11 and 14 as "We showed...", whereas one of the two papers originates from another laboratory. There are multiple proteins involved in the response to DNA damage initiated by DNA double strand breaks and at breaks appearing at stalled replication forks. A well described characteristic associated with DNA damage recognition is the post-translational modifications (phosphorylation, aceytlation, methylation, SUMOylation and ubiquitination) of these proteins which mediates the process and downstream events associated with this. The focus in the submission is on ATMmediated phosphorylation of the transcription factor SOG1 in Arabidapsis. At first glance this is not particularly novel since ATM has been shown to alter the functional activity of a number of transcription factors in mammalian cells. What is interesting is the absence of p53 and Chk2 in Arabidapsis and the less stringent requirement for ATR and ATM. Since SOG1 appears to have a role similar to p53 an investigation into the role of these proteins in the DNA damage response in Arabidapsis is warranted. This is a well designed study localising SOG1 to meristematic tissue using tagged protein and showing that it was in the nucleus and did not change in amount after DNA damage. They subsequently showed that it was phosphroylated in response to damage some of which depends on ATM. Constitutive phosphorylation depends on an unknown protein kinase. Specific Comments: 1. Need to refer to Fig 1 A in the text. 2. In order to rule out a role for ATR in SOG1 phosphorylation they used the atr-2 mutant. They should also check whether ATR phosphorylates SOG1 in response to replication fork blockage eg with HU or UV. 3. The ATM immunoprecipitators using GST-SOG1 and GST-SOG1(AQ) show that one or more of the 5 SQ sites are phosphorylated in vitro by ATM. Why not prepare individual SQ site mutants and determine the actual site(s)? In summary the work describes the new substrate for ATM but they should go a step further and identify the site at least in in vitro ATM kinase assays. We appreciated receiving the referees' reviews, and the opportunity to revise our manuscript. With this cover letter, we are now submitting the revised manuscript (EMBOR-2013-37244V1), entitled "ATM-mediated phosphorylation of SOG1 is essential for the DNA damage response in Arabidopsis", for publication in EMBO reports as a Scientific Report. We would like to thank the referees for their very thoughtful comments. Below, after summarizing the two major changes we have made, we provide detailed responses to the referees' individual comments and questions (the referees' remarks are in blue letters).
New data added: 1) Data on the effect of replication stress on hyperphosphorylation of SOG1. Referees #1 and #3 wanted to know whether ATR phosphorylates SOG1 in response to DNA replication stress. These results are presented in our new Fig. S5 .
2) Data on the in vitro ATM kinase assay using GST-SOG1 SQ site mutants. Referee #3 wanted to know the actual phosphorylated site(s) of SOG1, at least in in vitro ATM kinase assays. These results are presented in our new Fig. S6(C) .
…………………………………………………………………………………………….. Referee #1:
This is an interesting manuscript describing mechanisms of DNA damage signaling in Arabidopsis. Arabidopsis possesses ATM and ATR homologs, but not Chk1, Chk2 or p53 homologs. Instead, the transcription factor SOG1 has been shown to function downstream of ATM and ATR in a manner analogous to that of p53. In this manuscript, the authors show that serine-glutamine (SQ) motifs of SOG1 are phosphorylated by ATM in response to DNA damage, providing a mechanism by which ATM activates SOG1. Further, they show that a SOG1 AQ mutant (that cannot be phosphorylated by ATM) is functionally inactive.
We agree that this is a very important point, so we have added data on the effect of replication stress on the state of SOG1 phosphorylation. Fig. S5 shows that SOG1 was not hyperphosphorylated in response to hydroxyurea (a ribonucleotide reductase inhibitor) or aphidicolin (an inhibitor of DNA polymerase α) treatment. Therefore, in the revised manuscript, we have described our conclusion that SOG1 is phosphorylated in response to double-strand breaks (DSBs), but not to replication stress.
Thank you very much for this comment. It has been reported that mammalian p63 is regulated at both the transcriptional level and the protein level. p63 also accumulates intracellularly in response to genotoxic stress, like p53 (Katoh et al. Oncogene 2000 vol. 19 p3126; Okada et al. Exp. Cell Res. 2002 vol. 276 p194) . Therefore, we think that the regulation of SOG1 is not similar to that of p53 or p63. …………………………………………………………………………………………….. Referee #2:
We agree that gene silencing may not be the correct explanation. After reading this comment, we noticed that our atm-2 and atr-2 lines carry a single copy of the pSOG1::SOG1-Myc transgene (they are heterozygotes). We have confirmed this by PCR analysis. Then We have therefore changed the relevant sentence from "This may be due to indirect causes, such as gene silencing during several crosses" to "This may be because the atm-2 line is heterozygous for the SOG1-Myc transgene." (page 7, line 5).
A small, only "political" comment concerns the mentioning of papers referenced as #11 and 14 as "We showed...", whereas one of the two papers originates from another laboratory.
One of us (K. O. Y.) has worked in Dr. Britt's lab, and we apologize that "we" was written inadvertently. We have removed the first part of this sentence (page 6, line 23). There are multiple proteins involved in the response to DNA damage initiated by DNA double strand breaks and at breaks appearing at stalled replication forks. A well described characteristic associated with DNA damage recognition is the post-translational modifications (phosphorylation, aceytlation, methylation, SUMOylation and ubiquitination) of these proteins which mediates the process and downstream events associated with this. The focus in the submission is on ATMmediated phosphorylation of the transcription factor SOG1 in Arabidapsis. At first glance this is not particularly novel since ATM has been shown to alter the functional activity of a number of transcription factors in mammalian cells. What is interesting is the absence of p53 and Chk2 in Arabidapsis and the less stringent requirement for ATR and ATM. Since SOG1 appears to have a role similar to p53 an investigation into the role of these proteins in the DNA damage response in Arabidapsis is warranted. This is a well designed study localising SOG1 to meristematic tissue using tagged protein and showing that it was in the nucleus and did not change in amount after DNA damage. They subsequently showed that it was phosphroylated in response to damage some of which depends on ATM. Constitutive phosphorylation depends on an unknown protein kinase. Specific Comments: 2. In order to rule out a role for ATR in SOG1 phosphorylation they used the atr-2 mutant. They should also check whether ATR phosphorylates SOG1 in response to replication fork blockage eg with HU or UV.
Thank you for this remark. We agree that this is a very important point, and have added Fig. S5 to show the effect of replication stress on the state of SOG1 phosphorylation. SOG1 was not hyperphosphorylated in response to replication stress induced by hydroxyurea or aphidicolin treatment. Therefore, in the revised manuscript, we have described our conclusion that SOG1 is phosphorylated in response to DSBs, but not to replication stress.
3. The ATM immunoprecipitators using GST-SOG1 and GST-SOG1(AQ) show that one or more of the 5 SQ sites are phosphorylated in vitro by ATM. Why not prepare individual SQ site mutants and determine the actual site(s)? In summary the work describes the new substrate for ATM but they should go a step further and identify the site at least in in vitro ATM kinase assays.
To determine the actual SQ site(s) of SOG1 that are phosphorylated, we prepared GST-SOG1 whose serines in the five SQ motifs were substituted to alanine, individually and in various combinations (Appendix Table 1 and Appendix Figure 1 , included in this letter; and Fig. S6C ), and then performed in vitro human ATM kinase assays. The results showed that all mutated versions tested (except 5A) were phosphorylated, indicating that ATM phosphorylates multiple SQ sites. We found that the phosphorylation level of GST-SOG1(3A), (2A) or (356A) was much higher than that of GST-SOG1(WT) (Fig. S6C, Appendix Figure 1 ). Since GST forms a dimer under physiological conditions, GST-SOG1(WT) may not be effectively phosphorylated due to altered conformation; conversely, alanine substitutions may render GST-SOG1(3A), (2A) or (356A) more easily accessible to hATM.
We hope that these responses will satisfy all of the referees' concerns, and that the revised manuscript will now be acceptable for publication in EMBO reports. Table 1 . Construction of alanine mutants.
